IMA vs PTHS
Comparison between Ikena Oncology Inc (IMA, Company) and Channel Therapeutics Corporation (PTHS, Company).
Both IMA and PTHS are from the Healthcare sector.
IMA vs PTHS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
IMA
$97M
Winner
PTHS
$97M
Max Drawdown
IMA
98.82%
Winner
PTHS
88.73%
Sharpe Ratio
IMA
-0.92
Winner
PTHS
0.85
5Y Beta
Winner
IMA
0.63
PTHS
1.07
Industry
IMA
Biotechnology
PTHS
Biotechnology
P/E Ratio
Winner
IMA
-0.94
PTHS
-0.74
PEG Ratio
Winner
IMA
-0.04
PTHS
-0.00
Debt to Equity
IMA
0.00%
PTHS
0.00%
Free Cash Flow Yield
IMA
-59.64%
Winner
PTHS
-36.31%
P/S Ratio
IMA
N/A
PTHS
3.63
P/B Ratio
IMA
N/A
PTHS
2.87
IMA vs PTHS - Historical Returns
Returns include dividend reinvestment.
1M
IMA
-3.93%
Winner
PTHS
+9.03%
3M
IMA
+1.73%
Winner
PTHS
+10.03%
6M
IMA
-15.05%
Winner
PTHS
+39.07%
1Y
IMA
-58.66%
Winner
PTHS
+57.43%
5Y(CAGR)
IMA
-46.13%
PTHS
N/A
Max(CAGR)
IMA
-54.01%
Winner
PTHS
-18.76%
IMA vs PTHS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | IMA | PTHS |
|---|---|---|
| 2026 | -13.17% | -2.82% |
| 2025 | -65.15% | +328.54% |
| 2024 | -17.59% | -86.65% |
| 2023 | -24.81% | N/A |
| 2022 | -80.72% | N/A |
| 2021 | -60.81% | N/A |
IMA vs PTHS Drawdown Comparison
The maximum drawdown for IMA was -98.82%, occurring on Apr 6, 2026. This drawdown has not yet recovered.
The maximum drawdown for PTHS was -88.73%, occurring on Nov 19, 2024. This drawdown has not yet recovered.
The current IMA drawdown is -98.47%. The current PTHS drawdown is -40.37%.
| Rank | IMA | PTHS |
|---|---|---|
| #1 | -98.82% Mar 26, 2021 - Apr 6, 2026 | -88.73% Feb 16, 2024 - Nov 19, 2024 |
Correlation
Correlation between IMA and PTHS is -0.71 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
-0.71
-101
Select Stocks to Compare
Popular: IMA vs SPYPTHS vs SPY
More Comparisons
Compare with similar stocks